Verified by AISci
Public source attached
Source status for this paper in the current AISci reviewed snapshot.
- Primary source
- Theoretical and Natural Science
- Correction status
- none
- Evidence coverage
- 1 sources / 1 publishers
- Last metadata check
- Jul 19, 2026
Open primary sourceAI Reading Notes
Core signal
Structured notes generated from source-linked AISci metadata. Treat them as a reading aid, not a substitute for the paper.
- Core signal
- Research Progress of CRISPR-Cas Technology in the Treatment of Monogenic Diseases
- Field context
- Genomics and Gene Editing
- People and labs
- Yue Wang, Frontier Science Foundation, Ocean University of China
- Why it matters
- Recent source-backed research output for AISci Stage A browsing.
- Limits to check
- AISci rank score does not assess scientific quality or citation impact.
Research Workflow
Research Workflow
Recommended next steps for turning this signal into research action.
- Read original source
- Check DOI/OpenAlex
- Open relationship graph
- Review people and labs
- Open linked event for AISci context
- Prepare journal-club PPT: AISci action coming next
- Plan replication checks: AISci action coming next
Relationship evidence
Yue WangAuthor on Production of gene-edited cloned cattle embryos using the CRISPR/EOCas12i system.
AUTHORED BYoutgoing82% confidence
PRODUCED BYincoming82% confidence
ABOUT TOPICoutgoing82% confidence
Timeline
paperResearch Progress of CRISPR-Cas Technology in the Treatment of Monogenic Diseases